1. Surgical excision as the first therapeutic choice in single-muscle hemangiomas: a case series

Khodamorad Jamshidi; Milad Haji Agha Bozorgi; Hassan Assad Kassir; Alireza Mirzaei

Articles in Press, Accepted Manuscript, Available Online from 30 September 2019

http://dx.doi.org/10.22038/abjs.2019.40674.2098

Abstract
  Object: Conservative management is generally the primary treatment for intramuscular ‎hemangimas. However, many patients will require surgery later in their life, after suffering a long ‎period of pain. We aimed to evaluate the oncologic and functional outcomes of surgery as the ‎initial ...  Read More

Tumor
2. Epidemiologic Characteristics, Clinical Behavior, and Outcome of the Giant Cell Tumor of the Bone: A Retrospective Single-center Study

Khodamorad Jamshidi; Amin Karimi; Alireza Mirzaei

Volume 7, Issue 6 , November 2019, , Pages 538-544

http://dx.doi.org/10.22038/abjs.2018.35070.1924

Abstract
  Background: Giant cell tumor of bone (GCTB) is a locally aggressive lesion with an unpredictable behavior. Herein,the aim of this study was to evaluate the epidemiological characteristics, as well as clinical and functional outcomes ofGCTB in a relatively large series of patients.Methods: Patients with ...  Read More

Tumor
3. Giant Cell Tumor of the Sacrum: Series of 19 Patients and Review of the Literature

khodamorad Jamshidi; Abolfazl Bagherifard; Alireza Mirzaei; Mehrdad Bahrabadi

Volume 5, Issue 6 , November 2017, , Pages 443-450

http://dx.doi.org/10.22038/abjs.2017.19899.1548

Abstract
  There are still some debates regarding the best treatment of Giant Cell Tumor (GCT) of the sacrum. Since GCT of this location is rare, therapeutic strategies are mainly based on the treatment of GCT in other anatomic locations. The objective of this study was to evaluate the oncologic and clinical results ...  Read More

Tumor
4. Long-term Results of Osteoarticular Allograft Reconstruction in Children with Distal Femoral Bone Tumors

Khodamorad Jamshidi; Mehrdad Bahrabadi; Alireza Mirzaei

Volume 5, Issue 5 , September 2017, , Pages 296-301

http://dx.doi.org/10.22038/abjs.2016.7939

Abstract
  Background: There is no consensus regarding the best method of reconstruction in pediatric population following thewide resection of malignant bone tumors. More exploration of the complications of osteoarticular reconstruction leads toless existing controversy of this type of reconstruction, which is ...  Read More

5. Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones

Tina Shooshtarizadeh; Sajjadeh Movahedinia; Hassan Mostafavi; Khodamorad Jamshidi; Sam Sami

Volume 4, Issue 2 , April 2016, , Pages 166-172

http://dx.doi.org/10.22038/abjs.2016.6318

Abstract
     Aneurysmal bone cyst (ABC) is a benign expansile bone tumor, most commonly involving the medulla of long bones. ABC rarely arises within the cortex or in the subperiosteal region, radiographically mimicking other conditions, in particular surface osteosarcomathat is low-grade in nature and ...  Read More

6. Unusual Presentation of Synovial Sarcoma as Meniscal Cyst: A Case Report

Khodamorad Jamshidi; Hooman Yahazadeh; Abolfazl Bagherifard

Volume 3, Issue 4 , October 2015, , Pages 296-299

http://dx.doi.org/10.22038/abjs.2015.4657

Abstract
    Periarticular cyst and cystic soft tissue lesion around the knee are common. Synovial sarcoma is a rare and malignant soft tissue tumor accounting for approximately 5% of soft tissue sarcoma. A case is presented where a lesion adjacent to the joint line of the knee was diagnosed clinically and ...  Read More

7. Stage IE Primary Bone Lymphoma:Limb Salvage for Local Recurrence

Khodamorad Jamshidi; Mahmoud Jabalameli; Mohammad Ghorban Hoseini; Abolfazl Bagherifard

Volume 3, Issue 1 , January 2015, , Pages 39-44

http://dx.doi.org/10.22038/abjs.2015.3794

Abstract
  Background:   Primary bone lymphoma or non-Hodgkin lymphoma of bone is a rare disease. There are only a few case series of stage IE of this condition in medical literature. The aim of this study is to determine the rate of survival   for stage IE after combined modality treatment, the rate ...  Read More